Ventilator-Associated Tracheobronchitis: To Treat or Not to Treat?

Ventilator-associated tracheobronchitis (VAT) is an infection commonly affecting mechanically ventilated intubated patients. Several studies suggest that VAT is associated with increased duration of mechanical ventilation (MV) and length of intensive care unit (ICU) stay, and a presumptive increase...

Full description

Bibliographic Details
Main Authors: Despoina Koulenti, Kostoula Arvaniti, Mathew Judd, Natasha Lalos, Iona Tjoeng, Elena Xu, Apostolos Armaganidis, Jeffrey Lipman
Format: Article
Language:English
Published: MDPI AG 2020-01-01
Series:Antibiotics
Subjects:
Online Access:https://www.mdpi.com/2079-6382/9/2/51
_version_ 1828857679635808256
author Despoina Koulenti
Kostoula Arvaniti
Mathew Judd
Natasha Lalos
Iona Tjoeng
Elena Xu
Apostolos Armaganidis
Jeffrey Lipman
author_facet Despoina Koulenti
Kostoula Arvaniti
Mathew Judd
Natasha Lalos
Iona Tjoeng
Elena Xu
Apostolos Armaganidis
Jeffrey Lipman
author_sort Despoina Koulenti
collection DOAJ
description Ventilator-associated tracheobronchitis (VAT) is an infection commonly affecting mechanically ventilated intubated patients. Several studies suggest that VAT is associated with increased duration of mechanical ventilation (MV) and length of intensive care unit (ICU) stay, and a presumptive increase in healthcare costs. Uncertainties remain, however, regarding the cost/benefit balance of VAT treatment. The aim of this narrative review is to discuss the two fundamental and inter-related dilemmas regarding VAT, i.e., (i) how to diagnose VAT? and (ii) should we treat VAT? If yes, should we treat all cases or only selected ones? How should we treat in terms of antibiotic choice, route, treatment duration?
first_indexed 2024-12-13T01:42:40Z
format Article
id doaj.art-0bcd717bf24a4fb8b6a6396f3971d8d8
institution Directory Open Access Journal
issn 2079-6382
language English
last_indexed 2024-12-13T01:42:40Z
publishDate 2020-01-01
publisher MDPI AG
record_format Article
series Antibiotics
spelling doaj.art-0bcd717bf24a4fb8b6a6396f3971d8d82022-12-22T00:03:43ZengMDPI AGAntibiotics2079-63822020-01-01925110.3390/antibiotics9020051antibiotics9020051Ventilator-Associated Tracheobronchitis: To Treat or Not to Treat?Despoina Koulenti0Kostoula Arvaniti1Mathew Judd2Natasha Lalos3Iona Tjoeng4Elena Xu5Apostolos Armaganidis6Jeffrey Lipman7UQ Centre for Clinical Research, Faculty of Medicine, The University of Queensland, Brisbane 4029, AustraliaDepartment of Critical Care Medicine, ‘Papageorgiou’ General Hospital of Thessaloniki, Thessaloniki 56429, GreeceUQ Centre for Clinical Research, Faculty of Medicine, The University of Queensland, Brisbane 4029, AustraliaUQ Centre for Clinical Research, Faculty of Medicine, The University of Queensland, Brisbane 4029, AustraliaUQ Centre for Clinical Research, Faculty of Medicine, The University of Queensland, Brisbane 4029, AustraliaUQ Centre for Clinical Research, Faculty of Medicine, The University of Queensland, Brisbane 4029, Australia2nd Critical Care Department, ‘Attikon’ University Hospital, Athens 11632, GreeceUQ Centre for Clinical Research, Faculty of Medicine, The University of Queensland, Brisbane 4029, AustraliaVentilator-associated tracheobronchitis (VAT) is an infection commonly affecting mechanically ventilated intubated patients. Several studies suggest that VAT is associated with increased duration of mechanical ventilation (MV) and length of intensive care unit (ICU) stay, and a presumptive increase in healthcare costs. Uncertainties remain, however, regarding the cost/benefit balance of VAT treatment. The aim of this narrative review is to discuss the two fundamental and inter-related dilemmas regarding VAT, i.e., (i) how to diagnose VAT? and (ii) should we treat VAT? If yes, should we treat all cases or only selected ones? How should we treat in terms of antibiotic choice, route, treatment duration?https://www.mdpi.com/2079-6382/9/2/51ventilator-associated tracheobronchitisvatdiagnosistreatmentinhaled antibiotics
spellingShingle Despoina Koulenti
Kostoula Arvaniti
Mathew Judd
Natasha Lalos
Iona Tjoeng
Elena Xu
Apostolos Armaganidis
Jeffrey Lipman
Ventilator-Associated Tracheobronchitis: To Treat or Not to Treat?
Antibiotics
ventilator-associated tracheobronchitis
vat
diagnosis
treatment
inhaled antibiotics
title Ventilator-Associated Tracheobronchitis: To Treat or Not to Treat?
title_full Ventilator-Associated Tracheobronchitis: To Treat or Not to Treat?
title_fullStr Ventilator-Associated Tracheobronchitis: To Treat or Not to Treat?
title_full_unstemmed Ventilator-Associated Tracheobronchitis: To Treat or Not to Treat?
title_short Ventilator-Associated Tracheobronchitis: To Treat or Not to Treat?
title_sort ventilator associated tracheobronchitis to treat or not to treat
topic ventilator-associated tracheobronchitis
vat
diagnosis
treatment
inhaled antibiotics
url https://www.mdpi.com/2079-6382/9/2/51
work_keys_str_mv AT despoinakoulenti ventilatorassociatedtracheobronchitistotreatornottotreat
AT kostoulaarvaniti ventilatorassociatedtracheobronchitistotreatornottotreat
AT mathewjudd ventilatorassociatedtracheobronchitistotreatornottotreat
AT natashalalos ventilatorassociatedtracheobronchitistotreatornottotreat
AT ionatjoeng ventilatorassociatedtracheobronchitistotreatornottotreat
AT elenaxu ventilatorassociatedtracheobronchitistotreatornottotreat
AT apostolosarmaganidis ventilatorassociatedtracheobronchitistotreatornottotreat
AT jeffreylipman ventilatorassociatedtracheobronchitistotreatornottotreat